← FDA Drug Approvals (Drugs@FDA)

MESALAMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RISING · Approved 2025-04-14

Drug application

FDA Application #
ANDA219028
Application type
Abbreviated New Drug Application (Generic)
Brand name
MESALAMINE
Generic name
MESALAMINE
Active ingredients
MESALAMINE
Dosage form
SUPPOSITORY
Route
RECTAL
Marketing status
Prescription
Sponsor
RISING
Manufacturer
Rising Pharma Holdings, Inc.
First approval
2025-04-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown